These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 3871208

  • 21. Pretreatment of human peripheral blood lymphocytes with interleukin-2 or dexamethasone does not alter their response to Met-Enkephalin in a NK-cytotoxic assay.
    Martin-Kleiner I, Gabrilovac J.
    Immunopharmacol Immunotoxicol; 1996 Feb; 18(1):37-57. PubMed ID: 8683038
    [Abstract] [Full Text] [Related]

  • 22. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW, Shamim F, Hamon M, Macdonald ID, Prentice HG.
    Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
    [Abstract] [Full Text] [Related]

  • 23. An exoglycosidase-sensitive triggering site on NK cells which is coupled to transmethylation of membrane phospholipids.
    Kiyohara T, Dennis JW, Boegman RJ, Roder JC.
    J Immunol; 1985 Jul; 135(1):659-64. PubMed ID: 3923114
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Surface antigen determinants in subpopulations of peripheral blood NK- and T-cells separated by Percoll density fractionation.
    Schlesinger M, Lew F, Bekesi JG.
    J Clin Lab Immunol; 1984 Apr; 13(4):195-202. PubMed ID: 6204054
    [Abstract] [Full Text] [Related]

  • 27. [Effect of interferon-alpha (MOR-22) on human NK cell activity].
    Yanagihara Y, Tochizawa S, Ishii K, Hirai Y.
    Gan To Kagaku Ryoho; 1986 Feb; 13(2):342-8. PubMed ID: 3947110
    [Abstract] [Full Text] [Related]

  • 28. Limiting dilution analysis of the frequency of human T cells and large granular lymphocytes proliferating in response to interleukin 2. I. The effect of lectin on the proliferative frequency and cytotoxic activity of cultured lymphoid cells.
    Vose BM, Bonnard GD.
    J Immunol; 1983 Feb; 130(2):687-93. PubMed ID: 6600251
    [Abstract] [Full Text] [Related]

  • 29. Studies on the mechanism of natural killer cytotoxicity. II. coculture of human PBL with NK-sensitive or resistant cell lines stimulates release of natural killer cytotoxic factors (NKCF) selectively cytotoxic to NK-sensitive target cells.
    Wright SC, Weitzen ML, Kahle R, Granger GA, Bonavida B.
    J Immunol; 1983 May; 130(5):2479-83. PubMed ID: 6833762
    [Abstract] [Full Text] [Related]

  • 30. The heterogeneity of target recognition by lymphokine-activated killer precursor cells.
    Ibayashi Y, Gray JD, Golub SH, Daibo M, Yamaki T, Kawahara T, Kubota T, Hashi K.
    Jpn J Cancer Res; 1990 Sep; 81(9):927-35. PubMed ID: 2121694
    [Abstract] [Full Text] [Related]

  • 31. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
    Colotta F, Peri G, Villa A, Mantovani A.
    J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
    [Abstract] [Full Text] [Related]

  • 32. Identification of human natural killer soluble cytotoxic factors (NKCF) derived from NK-enriched lymphocyte populations: specificity of generation and killing.
    Farram E, Targan SR.
    J Immunol; 1983 Mar; 130(3):1252-6. PubMed ID: 6822733
    [Abstract] [Full Text] [Related]

  • 33. [The effect of sera of breast cancer patients on NK cell activity].
    Konjević G, Spuzić I.
    Srp Arh Celok Lek; 1995 Mar; 123(9-10):227-31. PubMed ID: 17974436
    [Abstract] [Full Text] [Related]

  • 34. Natural killer cells inhibit outgrowth of autologous Epstein-Barr virus-infected B lymphocytes.
    Kaplan J, Shope TC.
    Nat Immun Cell Growth Regul; 1985 Mar; 4(1):40-7. PubMed ID: 2993873
    [Abstract] [Full Text] [Related]

  • 35. Purine metabolites suppress proliferation of human NK cells through a lineage-specific purine receptor.
    Miller JS, Cervenka T, Lund J, Okazaki IJ, Moss J.
    J Immunol; 1999 Jun 15; 162(12):7376-82. PubMed ID: 10358189
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Interferon effect on cytotoxicity of peripheral blood and tumor-associated lymphocytes against human ovarian carcinoma cells.
    Allavena P, Introna M, Sessa C, Mangioni C, Mantovani A.
    J Natl Cancer Inst; 1982 Apr 15; 68(4):555-62. PubMed ID: 6175786
    [Abstract] [Full Text] [Related]

  • 39. Antileukemia activity of a natural killer cell line against human leukemias.
    Yan Y, Steinherz P, Klingemann HG, Dennig D, Childs BH, McGuirk J, O'Reilly RJ.
    Clin Cancer Res; 1998 Nov 15; 4(11):2859-68. PubMed ID: 9829753
    [Abstract] [Full Text] [Related]

  • 40. Studies on the mechanism of the human natural killer cell lethal hit: analysis of the mechanism of protease inhibition of the lethal hit.
    Hiserodt JC, Britvan L, Targan SR.
    J Immunol; 1983 Dec 15; 131(6):2705-9. PubMed ID: 6358352
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.